New Hydrogel to Help Treat Chronic Diseases Like Hepatitis C
The Editors at Hepatitis Central
July 1, 2015
Print this page
Can this gel really increase the therapeutic efficiency of HCV drugs, while reducing the need for frequent injections?
Researchers at the Institute of Bioengineering and Nanotechnology (IBN) of A*STAR have developed a drug-delivering hydrogel to treat chronic diseases such as hepatitis C, a liver disease that kills around 500,000 people worldwide every year.
“The new gel from IBN prevents premature drug release in the body. This allows for long-term drug delivery and reduces the side effects from frequent drug administration. We hope that our solution can improve the treatment and well-being of patients suffering from chronic diseases such as hepatitis C,” said IBN Executive Director Professor Jackie Y. Ying.
Continue reading this entire article:
http://phys.org/news/2015-06-gel-drugs-longer.html
HepatitisCentral.com provides information regarding hepatitis and liver disease. Comments are available to the community in order to discuss these topics and obtain answers to questions through community members. The Editors at HepatitisCentral.com will not be responding to questions or comments posed in article comments.